Compare ELAB & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELAB | CURX |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | United States |
| Employees | 34 | 6 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 9.4M |
| IPO Year | N/A | 2025 |
| Metric | ELAB | CURX |
|---|---|---|
| Price | $1.65 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 546.8K | 69.7K |
| Earning Date | 05-14-2026 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.26 |
| 52 Week High | $15.00 | $9.18 |
| Indicator | ELAB | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 45.47 |
| Support Level | $1.65 | $0.32 |
| Resistance Level | $2.28 | $0.40 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 2.29 | 40.94 |
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.